About this trial
The purpose of this study is to determine whether a 12-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among men with prostate cancer at high-risk of progression undergoing active surveillance.
The name of the study intervention involved in this study is:
Aerobic high-intensity interval training (HIIT) (training exercise intervention)
Eligibility criteria
Qualifiers
Age ≥18 years.
Histologically diagnosed with localized prostate cancer.
Initiating or undergoing active surveillance.
Having a higher risk of progression, defined as meeting one or more of the following: (1) favorable- intermediate risk prostate tumor at diagnosis, (2) obesity (body mass index ≥ 30), and/or (3) self- identified as Black or African American.
Disqualifiers
Received any invasive curative-intent treatment for prostate cancer, including surgery, chemotherapy, radiation therapy, and hormonal therapy.
Patients with metastasis and/or other active malignancies (except basal cell carcinoma) and/or receiving treatment for those malignancies.
Participating in any (>0 min/week) high-intensity exercise at the time of recruitment.
Having chronic medical conditions that are clinically unstable or uncontrolled with medications, deemed high-risk for exercise. These include but are not limited to unstable cardiac diseases, uncontrolled diabetes, and bone metastases with imminent risk of fracture.
Trial design
Treatments tested in this trial
- High-Intensity Interval Training Exercise Program
- High-Intensity Interval Training Exercise Program
Treatment groups
Sponsors and collaborators
Fred Hutchinson Cancer Center
Lead sponsor
Prostate Cancer Foundation
Collaborator